Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Posts Tagged ‘interventions’

« Older Entries

Cancer treatment could target inflammation in CVD

By on Sunday, May 5th, 2013 | No Comments

“Our results should act as a stimulus for further exploration of radionuclide based interventions in atherosclerosis.

Read More...

Factors For Eradicating Gastric Cancer Causing Bacterium H Pylori

By on Wednesday, February 13th, 2013 | No Comments

The bacterium Helicobacter pylori is one of the leading causes of gastric cancer worldwide, researchers analyzed the results of interventions that tried to eradicate the bacterium in several different Latin American population groups…

Read More...

Eradicating bacteria linked to gastric cancer

By on Wednesday, February 13th, 2013 | No Comments

In an analysis of the results of interventions to eradicate the bacterium Helicobacter pylori (a risk factor for gastric cancer) in seven diverse community populations in Latin America, researchers found that geographic site, demographic factors, adherence to initial therapy and infection recurrence may be as important as the choice of antibiotic regimen in H pylori eradication interventions, according to a new study.

Read More...

It’s Never Too Late To Quit: Smoking Cessation At Time Of Diagnosis Leads To Greater Success For Cancer Patients

By on Friday, January 25th, 2013 | No Comments

Lung and head and neck cancer patients who smoked before surgery are more likely to relapse than those who had quit before surgery, Moffitt Cancer Center researchers say. They found that smoking-relapse prevention interventions are needed immediately after surgery to help prevent relapse. The study was published in a recent issue of the journal Cancer…

Read More...

Study Examines Risk Reduction And Screening For Ovarian Cancer Among Women Following BRCA Testing

By on Wednesday, December 19th, 2012 | No Comments

Following BRCA testing, many women who are non-BRCA carriers undergo risk-reducing procedures and additional ovarian cancer screenings, despite limited data to determine the effectiveness of these interventions among the general population, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication…

Read More...

Study Examines Risk Reduction And Screening For Ovarian Cancer Among Women Following BRCA Testing

By on Wednesday, December 19th, 2012 | No Comments

Following BRCA testing, many women who are non-BRCA carriers undergo risk-reducing procedures and additional ovarian cancer screenings, despite limited data to determine the effectiveness of these interventions among the general population, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication…

Read More...

Study Examines Risk Reduction And Screening For Ovarian Cancer Among Women Following BRCA Testing

By on Wednesday, December 19th, 2012 | No Comments

Following BRCA testing, many women who are non-BRCA carriers undergo risk-reducing procedures and additional ovarian cancer screenings, despite limited data to determine the effectiveness of these interventions among the general population, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication…

Read More...

UCSF study examines risk reduction and screening for ovarian cancer among women following BRCA testing

By on Wednesday, December 19th, 2012 | No Comments

Following BRCA testing, many women who are non-BRCA carriers undergo risk-reducing procedures and additional ovarian cancer screenings, despite limited data to determine the effectiveness of these interventions among the general population.

Read More...

Identifying at-risk patients for adverse smoking outcomes: Models developed from cancer screening trial may help

By on Sunday, October 28th, 2012 | No Comments

Risk prediction models developed from an ancillary study of the Prostate Lung Colorectal and Ovarian Cancer Screening Trial may be useful in the public health sector for identifying individuals who are at risk for adverse smoking outcomes, such as relapse among former smokers and continued smoking among current smokers, and those who may benefit from relapse prevention and smoking cessation interventions, according to a new study.

Read More...

Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

By on Monday, September 24th, 2012 | No Comments

Condition :   Ovarian Cancer Interventions :   Drug: Veliparib;   Drug: Topotecan Sponsors :   Vejle Hospital;   Vejle Hospital;   Abbott Not yet recruiting – verified September 2012

Read More...
« Older Entries